台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    65.0
  • 漲跌
    ▼2.3
  • 漲幅
    -3.42%
  • 成交量
    434
  • 產業
    上櫃 生技醫療類股
  • 73人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
易威 (1799)籌碼相關-第一金-彰化 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1001/2202/1402/2803/1203/2404/0604/1604/2805/0805/10405060708090Jul '24Sep '24Nov '24Mar '25May '2560d90dAll

第一金-彰化 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/2400.00156.6056.50-1467-0.21%
2025/04/17259.1000.0058.6024890.41%
2025/03/1300.00479.8081.00-4603-0.66%
2025/03/12479.8000.0077.5045850.68%
2025/03/11179.2000.0081.5015570.18%
2025/03/1000.00272.4076.80-2518-0.39%
2025/03/0700.00372.0369.90-3496-0.60%
2025/03/0400.00068.9069.6004830.00%
2025/03/0300.00169.7069.60-1483-0.21%
2025/02/20165.9000.0071.0014970.20%
2025/02/17162.0000.0062.2015210.19%
2025/02/1300.00862.3162.80-8574-1.39%
2025/02/1200.00262.4061.90-2585-0.34%
2025/01/1700.00460.2058.60-4616-0.65%
2025/01/1600.00261.1061.40-2613-0.33%
2025/01/1400.00260.8062.90-2621-0.32%
2025/01/13365.6700.0062.8036270.48%
2024/12/31163.70164.0064.3006690.00%
2024/12/30167.4000.0066.7016920.14%
2024/12/27162.7000.0063.3016970.14%
2024/12/26369.1300.0066.6036920.43%
2024/12/25274.40176.0074.0016830.15%
2024/12/19162.0000.0062.7016950.14%
2024/12/11155.10154.9054.9006660.00%
2024/12/06265.15264.6064.3006510.00%
2024/11/2600.00170.6068.60-1681-0.15%
2024/11/2500.00172.0071.90-1681-0.15%
2024/11/22173.5000.0073.0016720.15%
2024/11/20169.0000.0067.4016660.15%
2024/11/12065.6000.0070.0006320.00%
2024/11/11270.5500.0070.1026060.33%
2024/11/08181.7000.0077.8016030.17%
2024/11/05185.1000.0084.9016360.16%
2024/10/28196.6000.0095.5016880.15%
2024/10/221102.0000.00107.0017260.14%
2024/10/212106.5000.00105.5027360.27%
2024/10/0900.003131.00119.00-3838-0.36%
2024/10/080124.001128.00126.00-1839-0.12%
2024/10/0400.000106.00106.5008130.00%
2024/10/01297.2000.0097.2027870.25%
2024/09/302108.0000.00108.0027770.26%
2024/09/274121.6300.00120.0047960.50%
2024/09/268134.1900.00133.0087851.02%
2024/09/252154.0000.00147.5027840.26%
2024/09/241158.0000.00159.0017890.13%
2024/09/2310160.0000.00158.00107941.26%
2024/09/203171.0000.00169.0037820.38%
2024/09/161175.5000.00175.5017800.13%
2024/08/2300.001228.50229.00-1798-0.13%
2024/08/211225.001216.00225.0008020.00%
2024/08/0500.001.1184.86180.00-1.1768-0.14%
2024/08/0200.002182.50177.50-2749-0.27%
2024/08/013170.0000.00175.5037320.41%
2024/07/170.1191.001.7188.74191.00-1.6589-0.27%
2024/07/1200.002162.00162.00-2544-0.37%
2024/07/021138.0000.00138.0014460.22%
2024/06/281119.0000.00130.0014130.24%
2024/06/201105.0000.00105.0013720.27%
2024/06/1100.001101.50101.50-1324-0.31%
2024/06/0600.00295.3095.00-2318-0.63%
2024/06/05398.1300.0098.6033150.95%
2024/05/2300.00792.90100.50-7286-2.44%
2024/05/2200.00193.6091.50-1260-0.38%
2024/05/21191.9013.392.9693.00-12.3250-4.93%
2024/05/2000.00286.3086.30-2238-0.84%
2024/05/1600.00875.0075.00-8226-3.53%
2024/05/1500.00674.2074.50-6234-2.56%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音